
| Serial Number | 98213336 |
| Word Mark | USJECT |
| Filing Date | Friday, October 6, 2023 |
| Status | 819 - SU - REGISTRATION REVIEW COMPLETE |
| Status Date | Wednesday, June 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 2, 2024 |
| Indication of Colors claimed | The color(s) red, white, blue, turquoise, and light turquoise is/are claimed as a feature of the mark. |
| Pseudo Mark | US INJECT |
| Goods and Services | Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research and development of injection devices for pharmaceutical use |
| Description of Mark | The mark consists of the stylized wording “USJECT” in which the stylized letters “US” are featured in red, white, and blue and feature various white star designs, which is to resemble an incomplete stylized American flag design, and the stylized letters “JECT” are featured in turquoise. A design of a syringe featured in turquoise and light turquoise with a single droplet design positioned at the end of the syringe that is also featured in turquoise and light turquoise is positioned above the stylized wording “USJECT”. The stylized wording and designs, as illustrated in the mark, are featured on top of a transparent rectangular background, which is not a claimed feature of the mark. |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, October 15, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, September 12, 2023 |
| First Use In Commerce Date | Tuesday, September 12, 2023 |
| Party Name | UNITHER PHARMACEUTICALS |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | 80084 AMIENS - FR |
| Party Name | UNITHER PHARMACEUTICALS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | 80084 AMIENS FR |
| Event Date | Event Description |
| Tuesday, October 10, 2023 | NEW APPLICATION ENTERED |
| Sunday, October 15, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 17, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, May 28, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, May 28, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, May 28, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 28, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, May 28, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, May 28, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, June 12, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 2, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 2, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 27, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, December 4, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 5, 2024 | SOU EXTENSION 1 FILED |
| Thursday, December 5, 2024 | SOU EXTENSION 1 GRANTED |
| Monday, March 3, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 25, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 25, 2025 | SOU EXTENSION 2 FILED |
| Monday, August 25, 2025 | SOU EXTENSION 2 GRANTED |
| Tuesday, August 26, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, February 26, 2026 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, February 26, 2026 | USE AMENDMENT FILED |
| Wednesday, June 10, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
| Wednesday, June 10, 2026 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, June 10, 2026 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |